(Q35878328)

10 August 2017

1 reference

title

Inflammation, immunity and vaccines for Helicobacter pylori (English)

1 reference

10 August 2017

0 references

Giuseppe Del Giudice

1

1 reference

10 August 2017

Pierre Michetti

series ordinal

2

1 reference

10 August 2017

publication date

1 January 2004

1 reference

10 August 2017

1 reference

10 August 2017

volume

9 Suppl 1

1 reference

10 August 2017

page(s)

23-28

1 reference

Gastric marginal zone lymphoma is associated with polymorphisms in genes involved in inflammatory response and antioxidative capacity

10 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1083-4389.2004.00245.X

Helicobacter pylori cagPathogenicity Island Is Associated with Reduced Expression of Interleukin-4 (IL-4) mRNA and Modulation of the IL-4δ2 mRNA Isoform in Human Gastric Mucosa

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1083-4389.2004.00245.X

Induction and regulation of Smad7 in the gastric mucosa of patients with Helicobacter pylori infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1083-4389.2004.00245.X

The Size of cagA Based on Repeat Sequence Has the Responsibility of the Location of Helicobacter pylori in the Gastric Mucus and the Degree of Gastric Mucosal Inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1083-4389.2004.00245.X

Helicobacter pylori upregulates matrilysin (MMP-7) in epithelial cells in vivo and in vitro in a Cag dependent manner.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1083-4389.2004.00245.X

Interactions between Inducible Nitric Oxide and Other Inflammatory Mediators during Helicobacter pylori Infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1083-4389.2004.00245.X

Lipid peroxidation in chronic gastritis; any influence of Helicobacter pylori?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1083-4389.2004.00245.X

Helicobacter pylori preferentially induces interleukin 12 (IL-12) rather than IL-6 or IL-10 in human dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1083-4389.2004.00245.X

Development of an interleukin-12-deficient mouse model that is permissive for colonization by a motile KE26695 strain of Helicobacter pylori

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1083-4389.2004.00245.X

Treatment of Helicobacter gastritis with IL-4 requires somatostatin

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1083-4389.2004.00245.X

Helicobacter pylori infection interferes with epithelial Stat6-mediated interleukin-4 signal transduction independent of cagA, cagE, or VacA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1083-4389.2004.00245.X

Role for complement in development of Helicobacter-induced gastritis in interleukin-10-deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1083-4389.2004.00245.X

Systemic Th1 immunization of mice against Helicobacter pylori infection with CpG oligodeoxynucleotides as adjuvants does not protect from infection but enhances gastritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1083-4389.2004.00245.X

Orally administered CpG oligodeoxynucleotide induces production of CXC and CC chemokines in the gastric mucosa and suppresses bacterial colonization in a mouse model of Helicobacter pylori infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1083-4389.2004.00245.X

Vaccine-induced protection against Helicobacter pylori in mice lacking both antibodies and interleukin-4.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1083-4389.2004.00245.X

Vaccine-induced reduction of Helicobacter pylori colonization in mice is interleukin-12 dependent but gamma interferon and inducible nitric oxide synthase independent

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1083-4389.2004.00245.X

Colonization of C57BL/6J and BALB/c wild-type and knockout mice with Helicobacter pylori: effect of vaccination and implications for innate and acquired immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1083-4389.2004.00245.X

Protective immunity against Helicobacter is characterized by a unique transcriptional signature

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1083-4389.2004.00245.X

CXCL13 is required for B1 cell homing, natural antibody production, and body cavity immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1083-4389.2004.00245.X

Helicobacter pylori-specific CD4+ CD25high regulatory T cells suppress memory T-cell responses to H. pylori in infected individuals

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1083-4389.2004.00245.X

Absence of CD4+CD25+ regulatory T cells is associated with a loss of regulation leading to increased pathology in Helicobacter pylori-infected mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1083-4389.2004.00245.X

Immunosuppressive and proinflammatory activities of the VacA toxin of Helicobacter pylori

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1083-4389.2004.00245.X

Helicobacter pylori vacuolating cytotoxin inhibits T lymphocyte activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1083-4389.2004.00245.X

The Helicobacter pylori vacuolating toxin inhibits T cell activation by two independent mechanisms.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1083-4389.2004.00245.X

The quest for a vaccine against Helicobacter pylori: how to move from mouse to man?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1083-4389.2004.00245.X

Enhanced mucosal and systemic immune responses to Helicobacter pylori antigens through mucosal priming followed by systemic boosting immunizations.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1083-4389.2004.00245.X

Comparison of different routes of vaccination for eliciting antibody responses in the human stomach

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1083-4389.2004.00245.X

B cell responses in gastric antrum and duodenum following oral inactivated Helicobacter pylori whole cell (HWC) vaccine and LT(R192G) in H pylori seronegative individuals

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1083-4389.2004.00245.X

Helicobacter in the developing world

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1083-4389.2004.00245.X

Passive immunity in Helicobacter-challenged neonatal mice conferred by immunized dams lasts until weaning

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1083-4389.2004.00245.X

Protective efficacy of anti-Helicobacter pylori immunity following systemic immunization of neonatal mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1083-4389.2004.00245.X

CTLA-4 blockade inhibits induction of Helicobacter pylori-associated gastritis in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1083-4389.2004.00245.X

10.1111/J.1083-4389.2004.00245.X

21 January 2018

Identifiers

DOI

1 reference

10 August 2017

1 reference